Stocks and Investing Stocks and Investing
Fri, March 24, 2023
Thu, March 23, 2023
Wed, March 22, 2023
Tue, March 21, 2023

Derek Archila Initiated (ZYME) at Buy and Held Target at $12 on, Mar 21st, 2023


Published on 2024-10-28 02:21:33 - WOPRAI, Derek Archila
  Print publication without navigation


Derek Archila of Wells Fargo, Initiated "Zymeworks Inc." (ZYME) at Buy and Held Target at $12 on, Mar 21st, 2023.

Derek has made no other calls on ZYME in the last 4 months.



There are 5 other peers that have a rating on ZYME. Out of the 5 peers that are also analyzing ZYME, 2 agree with Derek's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Andrew Berens of "SVB Leerink" Maintained at Hold with Increased Target to $10 on, Friday, January 20th, 2023
  • Gena Wang of "Barclays" Maintained at Hold with Increased Target to $9 on, Thursday, December 22nd, 2022


These are the ratings of the 3 analyists that currently disagree with Derek


  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $17 on, Friday, March 10th, 2023
  • Charles Zhou of "Guggenheim" Reiterated at Strong Buy and Held Target at $16 on, Wednesday, March 8th, 2023
  • Akash Tewari of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $11 on, Tuesday, December 20th, 2022